Vulvar cancer laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{CMG}} {{Vulvar cancer}} ==Overview== A suspicious lesion needs to undergo a biopsy that generally can be performed in an office setting under local anesthesia. Smal..." |
No edit summary |
||
(12 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
{{CMG}} | __NOTOC__ | ||
{{CMG}} {{AE}} {{sali}} | |||
{{Vulvar cancer}} | {{Vulvar cancer}} | ||
[[Human papilloma virus]] may be reported positive<ref name="pmid24505474">{{cite journal |vauthors=Nygård M, Hansen BT, Dillner J, Munk C, Oddsson K, Tryggvadottir L, Hortlund M, Liaw KL, Dasbach EJ, Kjær SK |title=Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance |journal=PLoS ONE |volume=9 |issue=2 |pages=e88323 |date=2014 |pmid=24505474 |pmc=3914976 |doi=10.1371/journal.pone.0088323 |url=}}</ref>. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Line 11: | Line 10: | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Medicine]] | |||
[[Category:Gynecology]] |
Latest revision as of 14:11, 22 May 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Syed Musadiq Ali M.B.B.S.[2]
Vulvar cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Vulvar cancer laboratory findings On the Web |
American Roentgen Ray Society Images of Vulvar cancer laboratory findings |
Risk calculators and risk factors for Vulvar cancer laboratory findings |
Human papilloma virus may be reported positive[1].
References
- ↑ Nygård M, Hansen BT, Dillner J, Munk C, Oddsson K, Tryggvadottir L, Hortlund M, Liaw KL, Dasbach EJ, Kjær SK (2014). "Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance". PLoS ONE. 9 (2): e88323. doi:10.1371/journal.pone.0088323. PMC 3914976. PMID 24505474.